Title |
A review of the off-label use of selamectin (Stronghold®/Revolution®) in dogs and cats
|
---|---|
Published in |
Acta Veterinaria Scandinavica, November 2008
|
DOI | 10.1186/1751-0147-50-46 |
Pubmed ID | |
Authors |
Maggie A Fisher, David J Shanks |
Abstract |
Since its introduction approximately seven years ago, selamectin (Stronghold/Revolution, Pfizer Inc.) has been used off-label to treat a number of ecto- and endoparasite conditions in dogs and cats. It has been used as a successful prophylactic against Dirofilaria repens and as a treatment for Aelurostrongylus abstrusus in cats. It has also been used to treat notoedric mange, infestation with the nasal mite Pneumonyssoides caninum, Cheyletiella spp. and Neotrombicula autumnalis infestations and larval Cordylobia anthropophaga infection. However, to date attempts to treat generalised canine demodicosis have not been successful. In all cases, treatment was apparently well tolerated by the host. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 59 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 8 | 14% |
Student > Bachelor | 7 | 12% |
Other | 5 | 8% |
Student > Ph. D. Student | 4 | 7% |
Student > Master | 4 | 7% |
Other | 14 | 24% |
Unknown | 17 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Veterinary Science and Veterinary Medicine | 22 | 37% |
Medicine and Dentistry | 9 | 15% |
Agricultural and Biological Sciences | 4 | 7% |
Biochemistry, Genetics and Molecular Biology | 2 | 3% |
Business, Management and Accounting | 1 | 2% |
Other | 2 | 3% |
Unknown | 19 | 32% |